Status:
UNKNOWN
Modulation of Inflammation by Medium Cut Off Membranes
Lead Sponsor:
Technical University of Munich
Conditions:
Cardiovascular Diseases
End Stage Renal Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study examines whether medium-cut off dialysis results in improved blood purification of large middle molecules e.g. inflammatory molecules compared to hemodialysis (HD) treatments with conventio...
Detailed Description
Cardiovascular events and sepsis remain the leading causes of mortality in patients on maintenance hemodialysis. Thus expectancy of life for these patients is comparable to the prognosis of metastasiz...
Eligibility Criteria
Inclusion
- time since initiation of dialysis \> 3 months
- age \> 18 years
Exclusion
- time since initiation of dialysis \< 3 months
- age \< 18 years
- ongoing acute or chronic infection/malignoma, because this will interfere with inflammatory baseline values
- major surgery less than 2 weeks before inclusion in the study
- pregnancy
- mental illness
- lack of written and informed consent
Key Trial Info
Start Date :
September 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03270371
Start Date
September 1 2017
End Date
February 1 2019
Last Update
September 1 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of nephrology, Klinikum rechts der Isar
München, Bavaria, Germany, 81675